Leukemia Clinical Trials in Arizona

Showing 141-160 of 670 trials

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

NCT01787409

This partially randomized clinical trial studies cholecalciferol in improving survival in patients with newly diagnosed cancer with vitamin D insufficiency. Vitamin D replacement may improve tumor response and survival and delay time to treatment in patients with cancer who are vitamin D insufficient.

Aggressive Non-Hodgkin LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-Cell Lymphoma+12 more

Mayo Clinic565 participantsStarted Mar 2013

Scottsdale, Arizona, United States • Atlanta, Georgia, United States • Iowa City, Iowa, United States +2 more locations

WITHDRAWNNA31 miles

UNITY VCS Vitreoretinal Surgery

NCT07054281

This purpose of this study is to compare the safety and effectiveness of two eye surgery systems-UNITY VCS and CONSTELLATION-in treating adults with vitreoretinal diseases or disorders.

Epiretinal MembraneMacular HoleVisually Significant Vitreous Floater+5 more

Alcon ResearchStarted Jan 2026

Scottsdale, Arizona, United States • Laguna Hills, California, United States • West Des Moines, Iowa, United States +5 more locations

PreviousPage 8 of 34Next

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

UNITY VCS Vitreoretinal Surgery

Leukemia Trials in Other Cities

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Electrochemical and Electrophysiological Study

A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

STimulation to Activate RespIration

A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation

MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.

A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors

Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Other Conditions in Arizona